438 related articles for article (PubMed ID: 23997115)
1. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
[TBL] [Abstract][Full Text] [Related]
2. FDA-approved drug labeling for the study of drug-induced liver injury.
Chen M; Vijay V; Shi Q; Liu Z; Fang H; Tong W
Drug Discov Today; 2011 Aug; 16(15-16):697-703. PubMed ID: 21624500
[TBL] [Abstract][Full Text] [Related]
3. Predicting drug-induced liver injury in human with Naïve Bayes classifier approach.
Zhang H; Ding L; Zou Y; Hu SQ; Huang HG; Kong WB; Zhang J
J Comput Aided Mol Des; 2016 Oct; 30(10):889-898. PubMed ID: 27640149
[TBL] [Abstract][Full Text] [Related]
4. In Silico Prediction of Drug-Induced Liver Injury Based on Ensemble Classifier Method.
Wang Y; Xiao Q; Chen P; Wang B
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443562
[TBL] [Abstract][Full Text] [Related]
5. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
Chen M; Borlak J; Tong W
Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
[TBL] [Abstract][Full Text] [Related]
6. Development of a Battery of
Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
[TBL] [Abstract][Full Text] [Related]
7. Integrating Drug's Mode of Action into Quantitative Structure-Activity Relationships for Improved Prediction of Drug-Induced Liver Injury.
Wu L; Liu Z; Auerbach S; Huang R; Chen M; McEuen K; Xu J; Fang H; Tong W
J Chem Inf Model; 2017 Apr; 57(4):1000-1006. PubMed ID: 28350954
[TBL] [Abstract][Full Text] [Related]
8. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities.
Matthews EJ; Ursem CJ; Kruhlak NL; Benz RD; Sabaté DA; Yang C; Klopman G; Contrera JF
Regul Toxicol Pharmacol; 2009 Jun; 54(1):23-42. PubMed ID: 19422098
[TBL] [Abstract][Full Text] [Related]
9. Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
Shimizu Y; Sasaki T; Takeshita JI; Watanabe M; Shizu R; Hosaka T; Yoshinari K
PLoS One; 2021; 16(6):e0253855. PubMed ID: 34170966
[TBL] [Abstract][Full Text] [Related]
10. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.
Hong H; Thakkar S; Chen M; Tong W
Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
12. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
13. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
14. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
[TBL] [Abstract][Full Text] [Related]
15. A compound attributes-based predictive model for drug induced liver injury in humans.
Liu Y; Gao H; He YD
PLoS One; 2020; 15(4):e0231252. PubMed ID: 32294131
[TBL] [Abstract][Full Text] [Related]
16. Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities.
Frid AA; Matthews EJ
Regul Toxicol Pharmacol; 2010 Apr; 56(3):276-89. PubMed ID: 19941924
[TBL] [Abstract][Full Text] [Related]
17. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
[TBL] [Abstract][Full Text] [Related]
18. An In Silico Model for Predicting Drug-Induced Hepatotoxicity.
He S; Ye T; Wang R; Zhang C; Zhang X; Sun G; Sun X
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999595
[TBL] [Abstract][Full Text] [Related]
19. Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.
Shin HK; Kang MG; Park D; Park T; Yoon S
Front Pharmacol; 2020; 11():67. PubMed ID: 32116729
[TBL] [Abstract][Full Text] [Related]
20. Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury.
McEuen K; Borlak J; Tong W; Chen M
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
